Shares of Viatris Inc. rallied 1.83% to $12.24 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.32% to 6,932.05 and the Dow ...
Viatris faces revenue declines, execution issues, and high debt post-merger. Click here to read my latest analysis of VTRS ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Viatris stock moves and what is driving sentiment Viatris (VTRS) has quietly climbed about 14% over the past month and roughly 21% in the past 3 months, even though the share price is still slightly ...
If you are wondering whether Viatris is quietly undervalued or just a value trap in disguise, you are in the right place and we will unpack what the current price is really telling us. The stock has ...
Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a healthcare company that provides a diverse portfolio of branded, ...
Viatris Inc. (VTRS) delivered second-quarter 2025 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate of 56 cents. The company recorded adjusted earnings of 69 cents per ...
Viatris (NASDAQ:VTRS) shares recorded modest gains in the premarket on Thursday after the Xanax maker announced positive outcomes to several Phase 3 trials alongside better-than-expected financials ...
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...
Did you lose money on investments in Viatris? If so, please visit Viatris Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your ...
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company ...
This was the stock's second consecutive day of gains.